Global Markets and Manufacturing Technologies for Protein Drugs

  • ID: 3743675
  • Report
  • Region: Global
  • 176 Pages
  • BCC Research
10 % OFF
until Apr 30th 2018
1 of 5
Technology Advancements in Protein Therapeutics Spurring Market Growth

FEATURED COMPANIES

  • Abbvie Inc.
  • Apotex Inc.
  • CSL Limited
  • Grifols USA LLC
  • Merck KGAA
  • Pfizer Inc
  • MORE
The global protein drugs market reached nearly $174.7 billion in 2015 and should reach nearly $248.7 billion by 2020 at a compound annual growth rate (CAGR) of 7.3% through 2020.

This report will provide:

- An overview of the markets for each major class of protein in the segments therapeutic monoclonal antibodies, cytokines, peptide hormones, vaccines, and blood products
- Analyses of global market trends, with data from 2014, estimates for 2015, and projections of compound annual growth rates (CAGRs) through 2020
- Discussion covering the strength and weaknesses of each type of technology in light of the new technologies, growing competition, and changing customer needs
- Examinations of current successes, including the size and sales forecast for each class in the next five years
- Evaluation of challenges such as delivery methods and side effects
- Consideration of issues regarding add-on products and patent protection
- Company profiles of major players

Scope of the report:

The scope of this study covers manufacturing of protein drugs technologies. Each market and its applications, regulatory environment, technology, market projections and market shares were analyzed. Technological issues include the latest trends and developments. This report covers the currently used six techniques in manufacturing of protein therapeutics, which includes fractionation from natural human/animal sources, microbial fermentation, cell culture, chemical synthesis, transgenics and embryonated eggs. The emerging market for enzyme inhibitors includes countries such as India, China, Japan, Korea, Taiwan, Canada, Africa, Australia and New Zealand. The protein drugs that are covered in this report are monoclonal antibodies, cytokines, peptide antibiotics, vaccines, enzymes and blood factors. The market is also analyzed on the basis of the manufacturing process used in making therapeutic protein drugs.

Also included in the report are relevant patent analysis and comprehensive profiles of companies that lead the manufacturing of the protein drug industry. Some of the major players of the market include Eli Lilly & Co., Abbvie Inc., F. Hoffmann-La Roche Ltd., Sanofi S.A., Novo Nordisk AG, Novartis AG, Merck & Co., Merck KGaA and Amgen Inc..
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbvie Inc.
  • Apotex Inc.
  • CSL Limited
  • Grifols USA LLC
  • Merck KGAA
  • Pfizer Inc
  • MORE
Chapter 1: Introduction
- Study Objectives
- Reasons For Doing This Study
- Contributions Of The Study And For Whom
- Scope Of The Study
- Methodology
- Information Sources
- Analysts' Credentials

Chapter 2: Executive Summary

- Table Summary : Global Revenue For Protein Drugs By Region, Through 2020
- Figure Summary : Global Revenue For Protein Drugs By Region, 2013-2020

Chapter 3: Overview

- History
- Pharmacological Classification Of Therapeutic Proteins
- Molecular Classification Of Therapeutic Proteins
- Manufacturing Technologies

Chapter 4: Regulatory Aspects

- Monoclonal Antibodies
- Therapeutic Enzymes
- Cytokines
- Peptide Hormones
- Vaccines
- Blood Products
- Peptide Antibiotics
- Recalls
- Safety Alerts

Chapter 5: New Developments

- Monoclonal Antibodies
- Vaccines
- Cytokines
- Peptide Hormones
- Peptide Antibiotics
- Therapeutic Enzymes
- Blood Products
- Mergers And Acquisitions

Chapter 6: Market Analysis By Type

- Market By Type
- Market By Region

Chapter 7: Market Analysis By Manufacturing Process

- Market By Manufacturing Process

Chapter 8: Industry Structure

- Peptide Hormones
- Vaccines
- Therapeutic Enzymes
- Monoclonal Antibodies
- Cytokines
- Blood Factors
- Peptide Antibiotics

Chapter 9: Patent Analysis

- Patents By Year
- Patents By Type
- Patents By Company
- Patents By Country
- Patents By Assignee

Chapter 10: Current Situation
- Factors Affecting The Protein Therapeutic Market

Chapter 11: Company Profiles

- Abbvie Inc.
- Actavis Inc.
- Alexion Pharmaceuticals
- Allergan PLC
- Amgen Inc
- Apotex Inc.
- Baxalta Inc
- Bayer Pharma AG
- Biogen Inc.
- Biomarin Pharmaceutical Inc
- Biotest Pharmaceuticals Corp.
- Bristol-Myers Squibb
- CSL Limited
- ELI Lilly
- F. Hoffmann-La Roche AG
- Fresenius Kabi USA
- Glaxosmithkline
- Grifols USA LLC
- Hospira Inc
- Johnson & Johnson
- Medimmune Llc
- Merck & Co, Inc
- Merck KGAA
- Mylan Inc.
- Novartis AG
- Novo Nordisk AG
- Octapharma AG
- Pfizer Inc
- Protein Sciences Corp.
- Revo Biologics Inc.
- Sandoz
- Sanofi Inc
- Seattle Genetics Inc.
- Spectrum Pharmaceuticals Inc
- Takeda Pharmaceutical U.S.A., Inc
- UCB Company
- Shire PLC (Viropharm Inc.)
- Vertex Pharmaceuticals

Chapter- 12: Appendix I - Abbreviations

List Of Tables

Summary Table : Global Revenue For Protein Drugs By Region, Through 2020
Table 1 : Evolution Of Therapeutic Proteins
Table 2 : Protein Drugs Made By Fractionation
Table 3 : Therapetic Drugs Produced By Microbial Fermentation
Table 4 : Protein Drugs Produced By Transgenic Animals, Plants And Microorganisms
Table 5 : Protein Drugs Made By Cell Culture
Table 6 : New Approvals Of Monoclonal Antibodies, 2013-October 2015
Table 7 : New Approvals In Therapeutic Enzymes, 2013-October 2015
Table 8 : New Approvals Of Cytokines, 2013-October 2015
Table 9 : New Approvals Of Peptide Hormones, 2013-October 2015
Table 10 : New Approvals Of Vaccines, 2013-October 2015
Table 11 : New Approvals Of Blood Products, 2013-October 2015
Table 12 : New Approvals Of Peptide Antibiotics, 2013-October 2015
Table 13 : Recalls, 2013-October 2015
Table 14 : Safety Alerts, 2013-October 2015
Table 15 : Pipeline Products Of Monoclonal Antibodies
Table 16 : Pipeline Products Of Vaccines
Table 17 : Pipeline Products Of Cytokines
Table 18 : Pipeline Products In Peptide Hormones
Table 19 : Pieplines In Peptide Antibiotics
Table 20 : Pipeline Products In Therapeutic Enzymes
Table 21 : Pipeline Products In Blood Products
Table 22 : Mergers And Acquisitions Of Top Pharmaceutical Companies
Table 23 : Global Revenue For Protein Drugs By Type, Through 2020
Table 24 : Market Share Of Protein Drugs By Type, 2014
Table 25 : Global Revenue For Peptide Hormones By Type, Through 2020
Table 26 : Global Revenue For Vaccines By Type, Through 2020
Table 27 : Global Revenue For Therapeutic Enzymes By Type, Through 2020
Table 28 : Global Revenue For Monoclonal Antibodies By Type, Through 2020
Table 29 : Global Revenue For Cytokines By Type, Through 2020
Table 30 : Global Revenue For Blood Factors By Type, Through 2020
Table 31 : Global Revenue For Peptide Antibiotics By Type, Through 2020
Table 32 : Global Revenue For Protein Drugs By Region, Through 2020
Table 33 : Market Share Of Protein Drugs By Region, 2014
Table 34 : Global Market For Peptide Hormones By Region, Through 2020
Table 35 : Global Revenue For Vaccines By Region, Through 2020
Table 36 : Global Market For Therapeutic Enzymes By Region, Through 2020
Table 37 : Global Revenue For Monoclonal Antibodies By Region, Through 2020
Table 38 : Global Revenue For Cytokines By Region, Through 2020
Table 39 : Global Revenue For Blood Factors By Region, Through 2020
Table 40 : Global Revenue For Peptide Antibiotics By Region, Through 2020
Table 41 : Global Revenue For Protein Drugs By Manufacturing Process, Through 2020
Table 42 : Market Share Of Protein Drugs By Manufacturing Process, 2014
Table 43 : Global Revenue For Peptide Hormones By Manufacturing Process, Through 2020
Table 44 : Global Revenue For Vaccines By Manufacturing Process, Through 2020
Table 45 : Global Revenue For Therapeutic Enzymes By Manufacturing Process, Through 2020
Table 46 : Global Revenue For Monoclonal Antibodies By Manufacturing Process, Through 2020
Table 47 : Global Revenue For Cytokines By Manufacturing Process, Through 2020
Table 48 : Global Revenue For Blood Factors By Manufacturing Process, Through 2020
Table 49 : Global Revenue For Peptide Antibiotics By Manufacturing Process, Through 2020
Table 50 : Leading Manufacturers/Suppliers Of Peptide Hormones, 2014
Table 51 : Market Share Of Manufacturers/Suppliers For Peptide Hormones, 2014
Table 52 : Leading Manufacturers/Suppliers Of Vaccines, 2014
Table 53 : Market Share Of Manufacturers/Suppliers For Vaccines, 2014
Table 54 : Leading Manufacturers/Suppliers Of Therapeutic Enzymes, 2014
Table 55 : Market Share Of Manufacturers/Suppliers For Therapeutic Enzymes, 2014
Table 56 : Leading Manufacturers/Suppliers Of Monoclonal Antibodies, 2014
Table 57 : Market Share Of Manufacturers/Suppliers For Monoclonal Antibodies, 2014
Table 58 : Leading Manufacturers/Suppliers Of Cytokines, 2014
Table 59 : Market Share Of Manufacturers/Suppliers For Cytokines, 2014
Table 60 : Leading Manufacturers/Suppliers Of Therapeutic Blood Products, 2014
Table 61 : Market Share Of Manufacturers/Suppliers For Recombinant Blood Products, 2014
Table 62 : Leading Manufacturers/Suppliers Of Peptide Antibiotics, 2014
Table 63 : Market Share Of Manufacturers/Suppliers For Peptide Antibiotics, 2014
Table 64 : Number Of Patents By Year, 2013-October 2015
Table 65 : Number Of Patents By Type, 2013-October 2015
Table 66 : Number Of Patents By Company, 2013-October 2015
Table 67 : Number Of Patents By Country, 2013-October 2015
Table 68 : Patent Shares By Country, 2013-October 2015 (%)
Table 69 : Number Of Patents By Assignee, 2013-October 2015

List Of Figures

Summary Figure : Global Revenue For Protein Drugs By Region, 2013-2020
Figure 1 : Global Revenue For Protein Drugs By Type, 2013-2020
Figure 2 : Market Share Of Protein Drugs By Type, 2014
Figure 3 : Global Revenue For Peptide Hormones By Type, 2013-2020
Figure 4 : Global Revenue For Vaccines By Type, 2013-2020
Figure 5 : Global Revenue For Therapeutic Enzymes By Type, 2013-2020
Figure 6 : Global Revenue For Monoclonal Antibodies By Type, 2013-2020
Figure 7 : Global Revenue For Cytokines By Type, 2013-2020
Figure 8 : Global Revenue For Blood Factors By Type, 2013-2020
Figure 9 : Global Revenue For Peptide Antibiotics By Type, 2013-2020
Figure 10 : Global Revenue For Protein Drugs By Region, 2013-2020
Figure 11 : Market Share Of Protein Drugs By Region, 2014
Figure 12 : Global Market For Peptide Hormones By Region, 2013-2020
Figure 13 : Global Revenue For Vaccines By Region, 2013-2020
Figure 14 : Global Market For Therapeutic Enzymes By Region, 2013-2020
Figure 15 : Global Revenue For Monoclonal Antibodies By Region, 2013-2020
Figure 16 : Global Revenue For Cytokines By Region, 2013-2020
Figure 17 : Global Revenue For Blood Factors By Region, 2013-2020
Figure 18 : Global Revenue For Peptide Antibiotics By Region, 2013-2020
Figure 19 : Global Revenue For Protein Drugs By Manufacturing Process, 2013-2020
Figure 20 : Market Share Of Protein Drugs By Manufacturing Process, 2014
Figure 21 : Global Revenue For Peptide Hormones By Manufacturing Process, 2013-2020
Figure 22 : Global Revenue For Vaccines By Manufacturing Process, 2013-2020
Figure 23 : Global Revenue For Therapeutic Enzymes By Manufacturing Process, 2013-2020
Figure 24 : Global Revenue For Monoclonal Antibodies By Manufacturing Process, 2013-2020
Figure 25 : Global Revenue For Cytokines By Manufacturing Process, 2013-2020
Figure 26 : Global Revenue For Blood Factors By Manufacturing Process, 2013-2020
Figure 27 : Global Revenue For Peptide Antibiotics By Manufacturing Process, 2013-2020
Figure 28 : Market Share Of Manufacturers/Suppliers For Peptide Hormones, 2014
Figure 29 : Market Share Of Manufacturers/Suppliers For Vaccines, 2014
Figure 30 : Market Share Of Manufacturers/Suppliers For Therapeutic Enzymes, 2014
Figure 31 : Market Share Of Manufacturers/Suppliers For Monoclonal Antibodies, 2014
Figure 32 : Market Share Of Manufacturers/Suppliers For Cytokines, 2014
Figure 33 : Market Share Of Manufacturers/Suppliers For Recombinant Blood Products, 2014
Figure 34 : Market Share Of Manufacturers/Suppliers For Peptide Antibiotics, 2014
Figure 35 : Number Of Patents By Year, 2013-October 2015
Figure 36 : Number Of Patents By Type, 2013-October 2015
Figure 37 : Patent Shares By Country, 2013-October 2015
Figure 38 : Number Of Patents By Assignee, 2013-October 2015
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
- Abbvie Inc.
- Actavis Inc.
- Alexion Pharmaceuticals
- Allergan PLC
- Amgen Inc
- Apotex Inc.
- Baxalta Inc
- Bayer Pharma AG
- Biogen Inc.
- Biomarin Pharmaceutical Inc
- Biotest Pharmaceuticals Corp.
- Bristol-Myers Squibb
- CSL Limited
- ELI Lilly
- F. Hoffmann-La Roche AG
- Fresenius Kabi USA
- Glaxosmithkline
- Grifols USA LLC
- Hospira Inc
- Johnson & Johnson
- Medimmune Llc
- Merck & Co, Inc
- Merck KGAA
- Mylan Inc.
- Novartis AG
- Novo Nordisk AG
- Octapharma AG
- Pfizer Inc
- Protein Sciences Corp.
- Revo Biologics Inc.
- Sandoz
- Sanofi Inc
- Seattle Genetics Inc.
- Spectrum Pharmaceuticals Inc
- Takeda Pharmaceutical U.S.A., Inc
- UCB Company
- Shire PLC (Viropharm Inc.)
- Vertex Pharmaceuticals
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll